International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
-
Publication Venue For
-
Oncologic outcomes of minimally invasive versus open radical hysterectomy for early stage cervical carcinoma and tumor size <
2 cm: a systematic review and meta-analysis..
31:983-990.
2021
-
Emergency department utilization by patients with gynecologic cancer in the United States..
31:585-593.
2021
-
Radiation Therapy for Recurrent Clear-Cell Cancer of the Ovary.
26:1608-1614.
2016
-
Does Omentectomy in Epithelial Ovarian Cancer Affect Survival? An Analysis of the Surveillance, Epidemiology, and End Results Database.
25:607-615.
2015
-
ENDOMETRIOSIS AND OVARIAN CANCER: AN INTERNATIONAL POOLED ANALYSIS.
24:439-440.
2014
-
IDENTIFICATION OF SIX NOVEL, COMMON VARIANT GENETIC SUSCEPTIBILITY LOCI FOR INVASIVE EPITHELIAL OVARIAN CANCER.
24:13-13.
2014
-
LIFETIME RISK OF OVARIAN CANCER BASED ON ENDOMETRIOSIS AND OTHER RISK FACTORS.
24:441-442.
2014
-
PROPHYLACTIC OOPHORECTOMY FOR HEREDITARY SMALL-CELL CARCINOMA OF THE OVARY, HYPERCALCEMIC TYPE.
24:961-962.
2014
-
Cytochrome P450 1A1 gene polymorphisms and endometrial cancer risk: a meta-analysis..
21:323-331.
2011
-
GSTM1 polymorphism, GSTT1 polymorphism, and cervical cancer risk: a meta-analysis..
20:1576-1580.
2010
-
Glutathione S-transferase M1, T1, and P1 polymorphisms and ovarian cancer risk: a meta-analysis..
20:732-737.
2010
-
Comparison of gracilis and rectus abdominis myocutaneous flap neovaginal reconstruction performed during radical pelvic surgery: flap-specific morbidity..
17:298-303.
2007
-
Salvage of isolated vaginal recurrences in women with surgical stage I endometrial cancer: a multiinstitutional experience..
17:886-889.
2007
-
High expression of insulin-like growth factor binding protein-2 messenger RNA in epithelial ovarian cancers produces elevated preoperative serum levels..
16:1529-1535.
2006
-
Identification of genes associated with ovarian cancer metastasis using microarray expression analysis..
16:1733-1745.
2006
-
Use of trastuzumab in the treatment of metastatic endometrial cancer..
16:1370-1373.
2006
-
Rectus abdominis myocutaneous flaps for neovaginal reconstruction after radical pelvic surgery..
15:542-548.
2005
-
The activity of letrozole in patients with advanced or recurrent endometrial cancer and correlation with biological markers--a study of the National Cancer Institute of Canada Clinical Trials Group..
14:650-658.
2004
-
Mutations in the PTEN tumor suppressor gene in cervical carcinomas.
8:489-493.
1998
-
RESULTS OF A RANDOMIZED PHASE II TRIAL OF PACLITAXEL AND CARBOPLATIN VERSUS BLEOMYCIN, ETOPOSIDE AND CISPLATIN FOR NEWLY DIAGNOSED AND RECURRENT CHEMONAIVE STROMAL OVARIAN TUMORS
2020
-
A PHASE III RANDOMIZED CONTROLLED TRIAL OF SECONDARY CYTOREDUCTIVE SURGERY (SCS) FOLLOWED BY PLATINUM-BASED CHEMOTHERAPY (PC) PLATINUM-SENSITIVE, RECURRENT OVARIAN CANCER (PSOC) - SURGICAL PARAMETERS
2018
-
GOG213
2018
-
PHASE II TRIAL OF NINTEDANIB IN PATIENTS WITH BEVACIZUMAB-RESISTANT RECURRENT EPITHELIAL OVARIAN, TUBAL, AND PERITONEAL CANCER
2018
-
Randomized phase II trial of carboplatin-paclitaxel compared to carboplatin-paclitaxel-trastuzumab in advanced or recurrent uterine serous carcinomas that overexpress Her2/Neu (NCT01367002)
2017
-
RISK PREDICTION FOR OVARIAN CANCER: EPIDEMIOLOGIC RISK FACTORS PLUS CONFIRMED GENETIC LOCI
2016